Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Insect Mol Biol ; 33(4): 323-337, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38367277

ABSTRACT

Adjustment of the cellular metabolism of pro-inflammatory macrophages is essential for their bactericidal function; however, it underlies the development of many human diseases if induced chronically. Therefore, intervention of macrophage metabolic polarisation has been recognised as a potent strategy for their treatment. Although many small-molecule inhibitors affecting macrophage metabolism have been identified, their in vivo administration requires a tool for macrophage-specific delivery to limit their potential side effects. Here, we establish Drosophila melanogaster as a simple experimental model for in vivo testing of macrophage-specific delivery tools. We found that yeast-derived glucan particles (GPs) are suitable for macrophage-specific delivery of small-molecule inhibitors. Systemic administration of GPs loaded with atorvastatin, the inhibitor of hydroxy-methyl-glutaryl-CoA reductase (Hmgcr), leads to intervention of mevalonate pathway specifically in macrophages, without affecting HMGCR activity in other tissues. Using this tool, we demonstrate that mevalonate pathway is essential for macrophage pro-inflammatory polarisation and individual's survival of infection.


Subject(s)
Atorvastatin , Drosophila melanogaster , Macrophages , Mevalonic Acid , Animals , Atorvastatin/pharmacology , Atorvastatin/administration & dosage , Macrophages/metabolism , Macrophages/drug effects , Mevalonic Acid/metabolism , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage , Glucans/pharmacology , Hydroxymethylglutaryl CoA Reductases/metabolism
2.
Int J Pharm ; 651: 123739, 2024 Feb 15.
Article in English | MEDLINE | ID: mdl-38145780

ABSTRACT

Spray drying is commonly used for producing amorphous solid dispersions to improve drug solubility. The development of such formulations typically relies on comprehensive excipient and composition screening, which requires the preparation of many spray-dried powder samples. This is both labour-intensive and time-consuming when carried out manually. In the present work, the formulation screening task was automated by coupling a laboratory spray dryer operated in a semi-continuous mode with custom-made add-ons, allowing for rapid, computer-controlled production of formulation samples with systematically varying composition. The practical use of the spray drying robot in formulation development was demonstrated on a case study of poorly water-soluble model drugs simvastatin and ezetimibe. Six different polymers and several drug:polymer ratios were screened for the enhancement of dissolution properties. From a pool of 28 spray-dried samples, ternary compositions containing Eudragit L100-55 were identified as the most suitable ones for further processing and characterisation. The ability to populate the formulation design space rapidly and automatically made it possible to construct maps of physico-chemical properties such as glass transition temperature or dissolution rate. The spray drying robot thus enables the acceleration of early formulation development and a deeper understanding of composition-property relationships for multi-component spray dried powders.


Subject(s)
Robotics , Spray Drying , Drug Compounding , Solubility , Polymers/chemistry
3.
Eur J Pharm Biopharm ; 168: 15-25, 2021 Nov.
Article in English | MEDLINE | ID: mdl-34411641

ABSTRACT

Yeast glucan particles are porous polysaccharide cell walls extracted from Saccharomyces cerevisiae. Being mildly immunogenic, they are efficiently phagocytosed and have therefore been proposed as possible vehicles for drug delivery. Using curcumin as a model poorly water-soluble drug, a systematic comparison of three different physical loading methods - incipient wetness impregnation, slurry evaporation, and spray drying - was carried out and their influence on the particle morphology, encapsulation efficiency, amorphous drug content and release kinetics was evaluated. It was found that yeast glucan particles can contain up to 30% wt. of curcumin in the amorphous form when prepared by slurry evaporation. The dissolution of curcumin from glucan particles lead to a supersaturated solution in asimilar way as amorphous solid dispersions do, despite the fact that glucan particles themselves do not dissolve. Bi-phasic dissolution tests revealed up to 4-fold acceleration of curcumin dissolution rate from amorphous glucan particles compared to its crystalline form. Crucially, glucan particles were shown to retain the ability to be recognised and phagocytosed even after drug encapsulation.


Subject(s)
Curcumin/administration & dosage , Drug Carriers/chemistry , Drug Delivery Systems , beta-Glucans/chemistry , Chemistry, Pharmaceutical/methods , Crystallization , Curcumin/chemistry , Drug Compounding/methods , Drug Liberation , Kinetics , Solubility , Water/chemistry
4.
Int J Biol Macromol ; 169: 443-451, 2021 Feb 01.
Article in English | MEDLINE | ID: mdl-33340625

ABSTRACT

Yeast glucan particles (GPs) are promising agents for the delivery of biologically active compounds as drugs. GPs possess their own biological activities and can act synergistically with their cargo. This study aimed to determine how incorporating artemisinin, ellagic acid, (-)-epigallocatechin gallate, morusin, or trans-resveratrol into GPs affects their anti-inflammatory and antioxidant potential in vitro. Two different methods - slurry evaporation and spray drying - were used to prepare composites (GPs + bioactive compound) and the anti-inflammatory and antioxidative properties of the resultant products were compared. Several of the natural compounds showed the beneficial effects of being combined with GPs. The materials prepared by spray drying showed greater activity than those made using a rotary evaporator. Natural compounds incorporated into yeast GPs showed greater anti-inflammatory potential in vitro than simple suspensions of these compounds as demonstrated by their inhibition of the activity of transcription factors NF-κB/AP-1 and the secretion of the pro-inflammatory cytokine TNF-α.


Subject(s)
Glucans/chemistry , Glucans/pharmacology , Anti-Inflammatory Agents/pharmacology , Antioxidants/pharmacology , Artemisinins/pharmacology , Catechin/analogs & derivatives , Catechin/chemistry , Catechin/pharmacology , Cytokines , Ellagic Acid/chemistry , Ellagic Acid/pharmacology , Flavonoids/chemistry , Flavonoids/pharmacology , Monocytes/drug effects , NF-kappa B , Resveratrol/chemistry , Resveratrol/pharmacology , Saccharomyces cerevisiae , Saccharomyces cerevisiae Proteins
5.
Int J Pharm ; 576: 118990, 2020 Feb 25.
Article in English | MEDLINE | ID: mdl-31899318

ABSTRACT

In this work, novel amorphous solid dispersions based on yeast glucan particles were produced. Yeast glucan particles are hollow and porous, and they are mainly composed of amorphous polysaccharides. We hypothesized that these particles are suitable candidates for the amorphization of drugs with low water solubility. Model drugs ibuprofen and curcumin were successfully encapsulated in glucan particles by spray drying. Different spray-drying parameters were tested to evaluate the influence of atomizing droplet size and initial solid content on encapsulation efficiency. It was shown that higher solid content and, more significantly, larger droplet sizes lead to higher encapsulation efficiencies. The encapsulation efficiency of ibuprofen (10 wt%) into glucan particles was considerably improved from 41.3 ± 0.5% to 64.3 ± 0.2% by increasing initial solid content and droplet size with the two-fluid nozzle. The spray drying process was further optimized by using the ultrasonic nozzle and it was possible to achieve complete encapsulation of ibuprofen and curcumin without any precipitation of the active compound outside of the glucan particles. Overall, it was possible to produce completely amorphous composites with outstanding wettability and dispersion properties, and with significantly faster dissolution rates when compared to the micronized crude drug.


Subject(s)
Curcumin/chemistry , Desiccation , Drug Carriers , Ibuprofen/chemistry , Saccharomyces cerevisiae/chemistry , Ultrasonics , beta-Glucans/chemistry , Aerosols , Drug Compounding , Drug Liberation , Kinetics , Particle Size , Solubility , beta-Glucans/isolation & purification
6.
Food Chem ; 188: 612-8, 2015 Dec 01.
Article in English | MEDLINE | ID: mdl-26041238

ABSTRACT

In this work, hydroalcoholic extracts of two mushrooms species, Suillus luteus (L.: Fries) (Sl) and Coprinopsis atramentaria (Bull.) (Ca), were studied for their synergistic antioxidant effect and their viability as functional food ingredients tested by incorporation into a food matrix (cottage cheese). In a first step, the individual extracts and a combination of both, showing synergistic effects (Sl:Ca, 1:1), were microencapsulated by spray-drying using maltodextrin as the encapsulating material. The incorporation of free extracts resulted in products with a higher initial antioxidant activity (t0) but declining after 7 days (t7), which was associated with their degradation. However, the cottage cheese enriched with the microencapsulated extracts, that have revealed a lower activity at the initial time, showed an increase at t7. This improvement can be explained by an effective protection provided by the microspheres together with a sustained release. Analyses performed on the studied cottage cheese samples showed the maintenance of the nutritional properties and no colour modifications were noticed.


Subject(s)
Agaricales/chemistry , Drug Compounding/methods , Functional Food/analysis , Plant Extracts/chemistry , Antioxidants
SELECTION OF CITATIONS
SEARCH DETAIL
...